NEW YORK, May 2 - Ambion is sitting pretty these days. The Austin, Texas-based RNA provider not only finds itself in the center of the RNAi technology explosion, it has the luxury of having raised $10.5 million in venture capital financing this week, just to have in its coffers in case it wants to make an acquisition or expand a business area.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.